These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5718817)

  • 1. [Experiences with a new antihypertensive agent (Tadip)].
    Becker L
    Med Welt; 1968 Jul; 30():1684-5. PubMed ID: 5718817
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic trials with the new antihypertensive agent Tadip].
    Stein G
    Med Klin; 1968 Sep; 63(37):1466-8. PubMed ID: 5730203
    [No Abstract]   [Full Text] [Related]  

  • 3. [The broad-spectrum antihypertensive agent Tadip in slight and moderate hypertension].
    Kempf E
    Med Monatsschr; 1968 Jun; 22(6):270-5. PubMed ID: 5720912
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of hypertension with Leron (cyclacenin) and Tadip (cyclacenin and alpha-methyldopa)].
    Stampfer E
    Wien Med Wochenschr; 1968 Jun; 118(24):551-4. PubMed ID: 5711781
    [No Abstract]   [Full Text] [Related]  

  • 5. [Double-blind assay of a new hypotensive agent of central action, guanfacine, compared with alpha-methyldopa].
    Jiménez Casado M; Canto J; Yapur H; Oller JM
    Rev Clin Esp; 1984 Jul 15-31; 174(1-2):41-4. PubMed ID: 6393236
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
    Malini PL; Strocchi E; Ambrosioni E; Magnani B
    Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of a new alpha-adrenoceptor agonist, guanfacine and alpha-methyldopa in the treatment of hypertension.
    Joshi RC; De A; Cameron EG
    Br J Clin Pract; 1984 Feb; 38(2):66-7, 71. PubMed ID: 6142723
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of arterial hypertension by Tadip].
    Grujić M; Perinović M; Robović Z
    Med Arh; 1969; 23(5):75-81. PubMed ID: 5201557
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antihypertensive activity of a new molecule, 2,6-dichloro-benzylidene aminoguanidine acetate].
    Chiummo R
    Minerva Med; 1975 Dec; 66(84):4546-50. PubMed ID: 1202408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New antihypertensive drugs].
    Vorburger C; Tuckman J
    Schweiz Med Wochenschr; 1972 Jul; 102(30):1033-9. PubMed ID: 4144646
    [No Abstract]   [Full Text] [Related]  

  • 11. [Controllable hypertension therapy with Tadip].
    Schütz E
    Med Klin; 1971 Jan; 66(4):121-6. PubMed ID: 5546736
    [No Abstract]   [Full Text] [Related]  

  • 12. [A controlled blind study of 4 antihypertensive agents (methyldopa and 3 sympatholytic agents)].
    Vejlsgaard V; Christensen M; Clausen E
    Ugeskr Laeger; 1967 May; 129(19):635-8. PubMed ID: 4877293
    [No Abstract]   [Full Text] [Related]  

  • 13. [Guanfacine (Estulic) in the monotherapy of essential hypertension, grades I and II, according to WHO].
    Mayer K; Lupínek Z; Janousek S; Podrouzková B
    Cas Lek Cesk; 1984 Oct; 123(43):1306-11. PubMed ID: 6391673
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of guanoclor and methyldopa in the treatment of severe hypertension.
    Mackinnon J; el-Baz LM
    Br J Clin Pract; 1971 Mar; 25(3):135-7. PubMed ID: 4929159
    [No Abstract]   [Full Text] [Related]  

  • 15. [Simplified treatment of hypertension using Tadip].
    Kumpmann U
    Med Welt; 1968 Nov; 46():2553-6. PubMed ID: 5731380
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experiences from medical practice with a combination of l-alpha-methyldopa and cyclazenin (Tadip)].
    Terhedebrügge A
    Med Welt; 1967 Dec; 48():2928-30. PubMed ID: 5610312
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hypertension].
    Kishimoto M
    Naika; 1971 Jun; 27(6):1123-36. PubMed ID: 5092024
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the blood pressure lowering effect of cyclazenin and a cyclazenin-alpha-methyldopa combination].
    Seige K; Preuss EG; Mörl H; Köhler I; Lantzsch W
    Med Welt; 1969 Mar; 10():520-6. PubMed ID: 5772239
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trial of a new antihypertensive agent associating Guanoxan sulfate with a thiazide diuretic].
    Linquette M; May JP; Cappoen JP
    Lille Med; 1972 Feb; 17():Suppl 2:183-6. PubMed ID: 5034400
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drugs in the management of arterial hypertension].
    Rev Clin Esp; 1969 Jan; 112(2):207. PubMed ID: 5769042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.